Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2001

View Archived Issues

Pilot study of thalidomide in myelodysplastic syndrome yields encouraging results

Mechanism of action of ecteinascidin 743 shown to involve nucleotide excision repair

Avasimibe lowers VLDL-C and triglycerides in patients with combined hyperlipidemia

AMPA receptor binding described for Lilly's LY-395153

Taisho and Yamanouchi form joint research agreement for new drug discovery

Patient recruitment for phase III trials of T-20 completed

Study of AVI BioPharma's third-generation antisense technology to begin

Atrix licenses Leuprogel Depot products in Australia and New Zealand

BioTransplant and Gambro enter distribution agreement for cell separation product line

New applications for irbesartan submitted in Europe and the U.S.

New radioligand for monitoring Parkinson's disease progression

E.C approves DepoCyte for treatment of lymphomatous meningitis

FDA advisory committee unanimously recommends approval of Baxter's Extraneal PD solution

European approval granted for Ketek, Aventis' first-in-class antibiotic

Seattle Genetics and Icos sign agreement for the MAb component of SGN-15

Scientists at Cubist synthesize new cyclic lipopeptides as antibacterial compounds

Selective CDK4 inhibitors for the treatment of proliferative diseases identified at Lilly

New orally active elastase inhibitors reported by Sanofi-Synthelabo

Cysteine protease inhibitors and their use described by Ono Pharmaceutical

University of Nebraska researchers disclose novel selective NMDA receptor modulating agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...